Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
International Journal of General Medicine|June 21, 2023
Development and Validation of an Algorithm for Thrombosis with Thrombocytopenia Syndrome (TTS) at Unusual SitesShayan Hobbi, Patrick Saunders-Hastings, Cindy Ke Zhou, et al.
Open Forum Infectious Diseases|February 18, 2021
Babesiosis Occurrence Among United States Medicare Beneficiaries, Ages 65 and Older, During 2006-2017: Overall and by State and County of ResidenceMikhail Menis, Barbee I Whitaker, Michael Wernecke, et al.
Emerging Infectious Diseases|January 20, 2012
Babesiosis among elderly Medicare beneficiaries, United States, 2006-2008Mikhail Menis, Steven A Anderson, Hector S Izurieta, et al.
Plos One|October 16, 2015
Babesiosis Occurrence among the Elderly in the United States, as Recorded in Large Medicare Databases during 2006-2013Mikhail Menis, Richard A Forshee, Sanjai Kumar, et al.
Transfusion|May 5, 2025
Performance of a whole blood immunoassay for tenofovir detection and correlation with self-reported pre-exposure prophylaxis use in HIV-negative men who have sex with men interested in blood donationRenata Buccheri, Barbee Whitaker, Lance M Pollack, et al.
Transfusion|March 27, 2009
Quantitative estimate of the risks and benefits of possible alternative blood donor deferral strategies for men who have had sex with menSteven A Anderson, Hong Yang, Lou M Gallagher, et al.
JAMA Internal Medicine|November 1, 2021
Risk of Guillain-Barré Syndrome Following Recombinant Zoster Vaccine in Medicare BeneficiariesRavi Goud, Bradley Lufkin, Jonathan Duffy, et al.
Vaccine|December 10, 2022
Surveillance of COVID-19 vaccine safety among elderly persons aged 65 years and olderHui-Lee Wong, Ellen Tworkoski, Cindy Ke Zhou, et al.
Vaccine|May 4, 2024
Assessment of potential adverse events following the 2022-2023 seasonal influenza vaccines among U.S. adults aged 65 years and olderXiangyu Chianti Shi, Joann F Gruber, Michelle Ondari, et al.
Vaccine|February 5, 2026
Febrile seizure risk following monovalent COVID-19 mRNA vaccination in US children aged 2-5 yearsSteven A Anderson, Elizabeth R Smith, Zhiruo Wan, et al.
Pageof 8